WEE1 tyrosine kinase, a novel epigenetic modifier

Trends in Genetics

Volumn 29, Issue 7, 2013, Pages 394-402

  Mahajan, Kiran ^a   Mahajan, Nupam P ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cancer; Cell cycle; Epigenetics; Histones; Tyrosine phosphorylation; WEE1

Indexed keywords

HISTONE H2B; PROTEIN TYROSINE KINASE; PROTEIN WEE1; TYROSINE; UNCLASSIFIED DRUG;

CANCER GENETICS; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CHROMATIN; DNA DAMAGE; DNA REPLICATION; DNA SYNTHESIS; EPIGENETICS; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; HISTONE PHOSPHORYLATION; HISTONE UBIQUITINATION; HUMAN; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STOICHIOMETRY;

ANIMALS; CELL CYCLE; CELL CYCLE PROTEINS; CHROMATIN; DNA REPLICATION; EPIGENESIS, GENETIC; GENETIC MARKERS; HISTONES; HUMANS; MITOSIS; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES;

PYRONIA TITHONUS;

EID: 84879607314     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2013.02.003     Document Type: Review

References (104)

1. Meeks-Wagner D., Hartwell L.H. Normal stoichiometry of histone dimer sets is necessary for high fidelity of mitotic chromosome transmission. Cell 1986, 44:43-52.
2. Osley M.A. The regulation of histone synthesis in the cell cycle. Annu. Rev. Biochem. 1991, 60:827-861.
3. Schwartzentruber J., et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-231.
4. Wu G., et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 2012, 44:251-253.
5. Khuong-Quang D.A., et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012, 124:439-447.
6. Singh R.K., et al. Histone levels are regulated by phosphorylation and ubiquitylation-dependent proteolysis. Nat. Cell Biol. 2009, 11:925-933.
7. Tran V., et al. Asymmetric division of Drosophila male germline stem cell shows asymmetric histone distribution. Science 2012, 338:679-682.
8. Medina R., et al. Epigenetic control of cell cycle-dependent histone gene expression is a principal component of the abbreviated pluripotent cell cycle. Mol. Cell. Biol. 2012, 32:3860-3871.
9. Meeks-Wagner D., et al. Isolation of two genes that affect mitotic chromosome transmission in S. cerevisiae. Cell 1986, 44:53-63.
10. Takayama Y., et al. Hsk1- and SCF(Pof3)-dependent proteolysis of S. pombe Ams2 ensures histone homeostasis and centromere function. Dev. Cell 2010, 18:385-396.
11. Mackinnon R.N., Campbell L.J. The role of dicentric chromosome formation and secondary centromere deletion in the evolution of myeloid malignancy. Genet. Res. Int. 2011, 2011:643628.
12. Heun P., et al. Mislocalization of the Drosophila centromere-specific histone CID promotes formation of functional ectopic kinetochores. Dev. Cell 2006, 10:303-315.
13. Cnp1 in fission yeast. PLoS Genet. 2012, 8:e1002985.
14. Gunjan A., Verreault A. A Rad53 kinase-dependent surveillance mechanism that regulates histone protein levels in S. cerevisiae. Cell 2003, 115:537-549.
15. Heintz N., et al. Regulation of human histone gene expression: kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle. Mol. Cell. Biol. 1983, 3:539-550.
16. NPAT by cyclin E/Cdk2 in Cajal bodies promotes histone gene transcription. Genes Dev. 2000, 14:2298-2313.
17. Mahajan K., et al. H2B Tyr37 phosphorylation suppresses expression of replication-dependent core histone genes. Nat. Struct. Mol. Biol. 2012, 19:930-937.
18. Marzluff W.F., et al. The human and mouse replication-dependent histone genes. Genomics 2002, 80:487-498.
19. Hereford L.M., et al. Cell-cycle regulation of yeast histone mRNA. Cell 1981, 24:367-375.
20. Hereford L., et al. Periodic transcription of yeast histone genes. Cell 1982, 30:305-310.
21. Marzluff W.F., et al. Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. 2008, 9:843-854.
22. Koseoglu M.M., et al. Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradation of stem-loop binding protein at the end of S phase. Mol. Cell. Biol. 2008, 28:4469-4479.
23. Krishnan N., et al. The prolyl isomerase Pin1 targets stem-loop binding protein (SLBP) to dissociate the SLBP-histone mRNA complex linking histone mRNA decay with SLBP ubiquitination. Mol. Cell. Biol. 2012, 32:4306-4322.
24. wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature 1991, 349:808-811.
25. McGowan C.H., Russell P. Cell cycle regulation of human WEE1. EMBO J. 1995, 14:2166-2175.
26. +, a gene encoding a protein kinase homolog. Cell 1987, 49:559-567.
27. + protein kinase regulates entry into mitosis. Nature 1989, 342:39-45.
28. Watanabe N., et al. Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J. 1995, 14:1878-1891.
29. Zhao J., et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. Genes Dev. 2000, 14:2283-2297.
30. Zhao J., et al. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes Dev. 1998, 12:456-461.
31. Yamane K., et al. Asf1/HIRA facilitate global histone deacetylation and associate with HP1 to promote nucleosome occupancy at heterochromatic loci. Mol. Cell 2011, 41:56-66.
32. Osley M.A., et al. Identification of sequences in a yeast histone promoter involved in periodic transcription. Cell 1986, 45:537-544.
33. Xu H., et al. Identification of a new set of cell cycle-regulatory genes that regulate S-phase transcription of histone genes in Saccharomyces cerevisiae. Mol. Cell. Biol. 1992, 12:5249-5259.
34. Hall C., et al. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression. Mol. Cell. Biol. 2001, 21:1854-1865.
35. Hartwell L.H., et al. Genetic control of the cell division cycle in yeast. Science 1974, 183:46-51.
36. Gray C.H., et al. The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase. EMBO J. 2003, 22:3524-3535.
37. Breitkreutz A., et al. A global protein kinase and phosphatase interaction network in yeast. Science 2010, 328:1043-1046.
38. Wei Y., et al. Phosphorylation of histone H3 at serine 10 is correlated with chromosome condensation during mitosis and meiosis in Tetrahymena. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:7480-7484.
39. Goto H., et al. Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation. J. Biol. Chem. 1999, 274:25543-25549.
40. Preuss U., et al. Novel mitosis-specific phosphorylation of histone H3 at Thr11 mediated by Dlk/ZIP kinase. Nucleic Acids Res. 2003, 31:878-885.
41. O'Sullivan R.J., et al. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat. Struct. Mol. Biol. 2010, 17:1218-1225.
42. Sobel R.E., et al. Conservation of deposition-related acetylation sites in newly synthesized histones H3 and H4. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:1237-1241.
43. Sirbu B.M., et al. Analysis of protein dynamics at active, stalled, and collapsed replication forks. Genes Dev. 2011, 25:1320-1327.
44. Ahmad A., et al. WD dipeptide motifs and LXXLL motif of chicken HIRA are essential for interactions with the p48 subunit of chromatin assembly factor-1 and histone deacetylase-2 in vitro and in vivo. Gene 2004, 342:125-136.
45. Chow J.P., et al. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J. Biol. Chem. 2003, 278:40815-40828.
46. Aligue R., et al. Regulation of Schizosaccharomyces pombe Wee1 tyrosine kinase. J. Biol. Chem. 1997, 272:13320-13325.
47. Rhind N., et al. Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 1997, 11:504-511.
48. Mir S.E., et al. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma. Cancer Cell 2010, 18:244-257.
49. Tominaga Y., et al. Murine Wee1 plays a critical role in cell cycle regulation and pre-implantation stages of embryonic development. Int. J. Biol. Sci. 2006, 2:161-170.
50. Beck H., et al. Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase. J. Cell Biol. 2010, 188:629-638.
51. Sorensen C.S., Syljuasen R.G. Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res. 2012, 40:477-486.
52. Smith J., et al. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 2010, 108:73-112.
53. Sorensen C.S., et al. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3:247-258.
54. Fasulo B., et al. Chk1 and Wee1 kinases coordinate DNA replication, chromosome condensation, and anaphase entry. Mol. Biol. Cell 2012, 23:1047-1057.
55. O'Connell M.J., et al. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 1997, 16:545-554.
56. Aarts M., et al. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Cancer Discov. 2012, 2:524-539.
57. Davies K.D., et al. Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation. Cancer Biol. Ther. 2011, 12:788-796.
58. Beck H., et al. Cyclin-dependent kinase suppression by WEE1 kinase protects the genome through control of replication initiation and nucleotide consumption. Mol. Cell. Biol. 2012, 32:4226-4236.
59. Dominguez-Kelly R., et al. Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease. J. Cell Biol. 2011, 194:567-579.
60. Katsuno Y., et al. Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3184-3189.
61. Romanowski P., et al. Interaction of Xenopus Cdc2 × cyclin A1 with the origin recognition complex. J. Biol. Chem. 2000, 275:4239-4243.
62. Wuarin J., et al. Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication. Cell 2002, 111:419-431.
63. Singh R.K., et al. Generation and management of excess histones during the cell cycle. Front. Biosci. 2009, 14:3145-3158.
64. Liang D., et al. Histone dosage regulates DNA damage sensitivity in a checkpoint-independent manner by the homologous recombination pathway. Nucleic Acids Res. 2012, 40:9604-9620.
65. Singh R.K., et al. Novel E3 ubiquitin ligases that regulate histone protein levels in the budding yeast Saccharomyces cerevisiae. PLoS ONE 2012, 7:e36295.
66. Reis C.C., Campbell J.L. Contribution of Trf4/5 and the nuclear exosome to genome stability through regulation of histone mRNA levels in Saccharomyces cerevisiae. Genetics 2007, 175:993-1010.
67. Wuchty S., et al. Prediction of associations between microRNAs and gene expression in glioma biology. PLoS ONE 2011, 6:e14681.
68. Iorns E., et al. Integrated functional, gene expression and genomic analysis for the identification of cancer targets. PLoS ONE 2009, 4:e5120.
69. Murrow L.M., et al. Identification of WEE1 as a potential molecular target in cancer cells by RNAi screening of the human tyrosine kinome. Breast Cancer Res. Treat. 2010, 122:347-357.
70. Magnussen G.I., et al. High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy. PLoS ONE 2012, 7:e38254.
71. Hirai H., et al. Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents. Mol. Cancer Ther. 2009, 8:2992-3000.
72. 2 checkpoint activation with the Wee-1 inhibitor MK-1775 in glioblastoma cell lines. Mol. Cancer Ther. 2011, 10:2405-2414.
73. Hirai H., et al. MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil. Cancer Biol. Ther. 2010, 9:514-522.
74. Stathis A., Oza A. Targeting Wee1-like protein kinase to treat cancer. Drug News Perspect. 2010, 23:425-429.
75. Bridges K.A., et al. MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells. Clin. Cancer Res. 2011, 17:5638-5648.
76. De Witt Hamer P.C., et al. WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe. Clin. Cancer Res. 2011, 17:4200-4207.
77. Mack G.S. To selectivity and beyond. Nat. Biotechnol. 2010, 28:1259-1266.
78. Morin R.D., et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011, 476:298-303.
79. Morin R.D., et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat. Genet. 2010, 42:181-185.
80. McCabe M.T., et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2989-2994.
81. Wigle T.J., et al. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states. FEBS Lett. 2011, 585:3011-3014.
82. Yap D.B., et al. Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation. Blood 2011, 117:2451-2459.
83. Knutson S.K., et al. A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. Nat. Chem. Biol. 2012, 8:890-896.
84. McCabe M.T., et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012, 492:108-112.
85. Sturm D., et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012, 22:425-437.
86. Trujillo K.M., Osley M.A. A role for H2B ubiquitylation in DNA replication. Mol. Cell 2012, 48:734-746.
87. Lee J.S., et al. Codependency of H2B monoubiquitination and nucleosome reassembly on Chd1. Genes Dev. 2012, 26:914-919.
88. Moyal L., et al. Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol. Cell 2011, 41:529-542.
89. Han M., et al. Histone H2B repression causes cell-cycle-specific arrest in yeast: effects on chromosomal segregation, replication, and transcription. Cell 1987, 48:589-597.
90. Clark-Adams C.D., et al. Changes in histone gene dosage alter transcription in yeast. Genes Dev. 1988, 2:150-159.
91. Brown D.T., et al. Differential effect of H1 variant overexpression on cell cycle progression and gene expression. Nucleic Acids Res. 1996, 24:486-493.
92. Gunjan A., et al. Effects of H1 histone variant overexpression on chromatin structure. J. Biol. Chem. 1999, 274:37950-37956.
93. Sullivan E., et al. Drosophila stem loop binding protein coordinates accumulation of mature histone mRNA with cell cycle progression. Genes Dev. 2001, 15:173-187.
94. Fan Y., et al. H1 linker histones are essential for mouse development and affect nucleosome spacing in vivo. Mol. Cell. Biol. 2003, 23:4559-4572.
95. Prado F., Aguilera A. Partial depletion of histone H4 increases homologous recombination-mediated genetic instability. Mol. Cell. Biol. 2005, 25:1526-1536.
96. Cox S.G., et al. An essential role of variant histone h3.3 for ectomesenchyme potential of the cranial neural crest. PLoS Genet. 2012, 8:e1002938.
97. Xiao A., et al. WSTF regulates the H2A.X. DNA damage response via a novel tyrosine kinase activity. Nature 2009, 457:57-62.
98. Dawson M.A., et al. JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin. Nature 2009, 461:819-822.
99. Cook P.J., et al. Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 2009, 458:591-596.
100. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
101. Yamagishi Y., et al. Heterochromatin links to centromeric protection by recruiting shugoshin. Nature 2008, 455:251-255.
102. Panteleeva I., et al. HP1alpha guides neuronal fate by timing E2F-targeted genes silencing during terminal differentiation. EMBO J. 2007, 26:3616-3628.
103. Dawson M.A., et al. Three distinct patterns of histone H3Y41 phosphorylation mark active genes. Cell Rep. 2012, 2s:470-477.
104. Griffiths D.S., et al. LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. Nat. Cell Biol. 2011, 13:13-21.